Patent · US Active

Liver disease

US12150945B2 · kind B2 · utility

0Cited by
252References
30Claims
0Family size

Inventors

Key dates

Filing dateJul 19, 2019
Grant dateNov 26, 2024
Priority date
Expiry dateNov 13, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/52
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Methods of treating a liver disease or condition, or a symptom thereof, in a subject in need of treatment, are disclosed and described. One method comprises orally administering to a subject, a pharmaceutical composition having an amount of a testosterone, or an ester thereof, sufficient to treat the liver disease or condition, or symptom thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.